But in this case the mice carried human tumours - the drug effect was not on the mice, it was on the tumours. I think that is an important distinction.
Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed, page-19
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.010(8.33%) |
Mkt cap ! $37.99M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 13.0¢ | 11.5¢ | $13.20K | 110.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 56600 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 160305 | 2 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| NOX (ASX) Chart |